EZZ Life Science Holdings ASX:EZZ
Glenn Cross is currently serving as the Non Executive Director and Chair at EZZ Life Science Holdings since December 2021. Additionally, Glenn Cross holds the position of Director at Horizon 3 Biotech Fund, a role undertaken since August 2020.
This person is not in any teams
EZZ Life Science Holdings ASX:EZZ
EZZ Life Science Holdings is a genomic life sciences company. They offer genomic research and development to address four key human health challenges, genetic longevity, human papillomavirus, helicobacter pylori, and weight management.